Implementation of ward-based clinical pharmacy services in Belgium-description of the impact on a geriatric unit

Annals of Pharmacotherapy

Volumn 40, Issue 4, 2006, Pages 720-728

  Spinewine, Anne ^a   Dhillon, Soraya ^b   Mallet, Louise ^c   Tulkens, Paul M ^a   Wilmotte, Léon ^d   Swine, Christian ^e  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

Belgium; Clinical pharmacy; Drug related problems; Frail elderly; Pharmaceutical care

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTIANEMIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIULCER AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN DERIVATIVE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; VITAMIN D;

AGED; ARTICLE; BELGIUM; CLINICAL PHARMACY; CONTROLLED STUDY; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG MISUSE; DRUG USE; FEMALE; GERIATRICS; HEALTH CARE UTILIZATION; HEALTH SERVICE; HOSPITAL DEPARTMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PRIORITY JOURNAL; UNITED KINGDOM;

AGED, 80 AND OVER; BELGIUM; DRUG THERAPY; HEALTH SERVICES FOR THE AGED; HOSPITAL DEPARTMENTS; HUMANS; PHARMACY SERVICE, HOSPITAL;

EID: 33646270913     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G515     Document Type: Article

References (30)

1. Barber N. Towards a philosophy of clinical pharmacy. Pharm J 1996;257:289-91.
2. Hatoum HT, Catizone C, Hutchinson RA, Purohit A. An eleven-year review of the pharmacy literature: documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm 1986;20:33-48.
3. Child D, Cantrill JA, Cooke J. Effectiveness of hospital pharmacy: where is the evidence? Guild of Health Care Pharmacists, 2001. www.ghp.org.uk/default. asp?cid=398&ed=13185 (accessed 2005 Aug 22).
4. LeBlanc JM, Dasta JF. Scope of international hospital pharmacy practice. Ann Pharmacother 2005;39:183-91. Epub 14 Dec 2004. DOI 10.1345/aph.1E317
5. Willems L, Raymakers A, Sermeus W, Vleugels A, Laekeman G. Survey of hospital pharmacy practice in Flemish-speaking Belgium. Am J Health Syst Pharm 2005;62:321-4.
6. Spinewine A, Dhillon S. Clinical pharmacy practice: implications for pharmacy education in Belgium. Pharm Educ 2002;2:75-81. DOI 10.1080/ 1560221021000030160
7. Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001;49:200-9. DOI 10.1046/j.1532-5415.2001.49042.x
8. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990;150:841-5.
9. Hanlon JT, Artz MB, Pieper CF, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 2004;38:9-14. DOI 10.1345/aph.1D313
10. Gray SL, Mahoney JE, Blough DK. Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 1999;33:1147-53. DOI 10.1345/aph.19036
11. Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004;116:394-401. DOI 10.1016/j.amjmed.2003.10.031
12. Owens NJ, Sherburne NJ, Silliman RA, Fretwell MD. The Senior Care Study. The optimal use of medications in acutely ill older patients. J Am Geriatr Soc 1990;38:1082-7.
13. Cipolle RJ, Strand LM, Morley PC, eds. Pharmaceutical care practice: the clinician's guide. 2nd ed. New-York: McGraw-Hill, 2004.
14. Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992;45:1045-51.
15. World Health Organization (WHO) Collaborating Centre for Drugs Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification system. Oslo, Norway: WHO Collaborating Centre. www.whocc. no/actddd/ (accessed 2005 Oct 17).
16. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
17. van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004;38:859-67. Epub 30 Mar 2004. DOI 10.1345/aph.1D182
18. Hatoum HT, Hutchinson RA, Witte KW, Newby GP. Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm 1988;22:252-9.
19. Dooley MJ, Allen KM, Doecke CJ, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol 2004;57:513-21. DOI 10.1046/j.1365-2125.2003.02029.x
20. Kruse W, Rampmaier J, Frauenrath-Volkers C, et al. Drug-prescribing patterns in old age. A study of the impact of hospitalization on drug prescriptions and follow-up survey in patients 75 years and older. Eur J Clin Pharmacol 1991;41:441-7.
21. Petrie A, Sabin S. Assessing agreement. In: Petrie A, Sabin C, eds. Medical statistics at a glance. Oxford: Blackwell Science, 2000:93-5.
22. Beuzit K, Arnaud A, Remblier C, Haas M, Perault M-C. Study of prescription in a geriatric institution. J Pharm Clin 2003;22:18-22. French.
23. Sellors J, Kaczorowski J, Sellors C, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ 2003;169:17-22.
24. Feldstein A, Elmer PJ, Orwoll E, Herson M, Hillier T. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Arch Intern Med 2003;163:2165-72.
25. Mendelson G, Aronow WS. Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke. J Am Geriatr Soc 1998;46:1423-4.
26. Bernabei R, Gambassi G, Lapane K, et al. Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 1998;279:1877-82.
27. Harder S, Fischer P, Krause-Schafer M, et al. Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular disease from Germany. Eur J Clin Pharmacol 2005;60:797-805. DOI 10.1007/s00228-004-0838-9
28. Schmidt IK, Claesson CB, Westerholm B, Nilsson LG. Physician and staff assessment of drug interventions and outcomes in Swedish nursing homes. Ann Pharmacother 1998;32:27-32. DOI 10.1345/aph.17104
29. Blix HS, Viktil KK, Reikvam A, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J clin Pharmacol 2004;60:651-8. DOI 10.1007/s00228-004-0830-4
30. Hajjar ER, Hanlon JT, Artz MB, et al. Adverse drug reaction risk factors in older patients. Am J Geriatr Pharmacother 2004;1:82-9. DOI 10.1016/51543-5946(03)90004-3